The following are excerpts from the newsletter

May 16, 2013

  • Administering a saline flush "site unseen" can lead to a wrong route error
  • Null sign easily misread
    A zero written with a slash through it (Ø) to differentiate it from the letter O can lead to medication errors due to misinterpretation as the number 4, 6, 8, or 9.
  • HYDROmorphone available in 0.5 mg prefilled syringe
    As a result of serious adverse drug events, FDA reduced the recommended starting dose of HYDROmorphone to 0.2-1 mg in June 2011. To address these lower doses, Hospira recently released HYDROmorphone 0.5 mg/0.5 mL injection in its proprietary iSecure prefilled unit-dose syringe.
  • New ideas to address drug shortages
    On April 18, 2013, ISMP joined the American Society of Health-System Pharmacists (ASHP), the American Hospital Association (AHA), the American Society of Anesthesiologists (ASA), and the American Society of Clinical Oncology (ASCO) in co-convening a follow-up meeting to address the current drug shortage situation.
  • Name confusion with new cancer drugs
    Two new oral chemotherapy agents have names that may cause confusion. Pazopanib (VOTRIENT) is used to treat renal cell cancer, thyroid cancer, and soft tissue sarcoma, while ponatinib (ICLUSIG) is used to treat chronic myelogenous leukemia and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia.

Acute Care Main Page
Current Issue
Past Issues
Highlighted articles
Action Agendas
  - Free Nursing CEs
Special Alerts
Group Purchasing Subscription
Newsletter Editions
Acute Care
Community/Ambulatory Care
Nurse AdviseERR
Long-Term Care AdviseERR
Safe Medicine
Home | Contact UsEmployment  |   Legal Notices | Privacy Policy | Help Support ISMP
 Med-ERRS | Medication Safety Officer Society Medication Safety Officers Society | Consumer Medication Safety For consumers
ISMP Canada | ISMP Spain  | ISMP Brasil  | International Group  | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2018 Institute for Safe Medication Practices. All rights reserved